ProCAncer-I at the International Cancer Imaging Society Meeting in Boston

Published on: September 16, 2022
Categories: News

Really glad to have been a part of the 21st Annual Teaching course at the International Cancer Imaging Society Meeting in Boston! The meeting had the title: “Cancer Imaging: An all-inclusive specialty” and was held on Monday 12th to Wednesday 14th September 2022 at Hotel Commonwealth, 500 Commonwealth Avenue, Boston

Prof Mu Koh from The Royal Marsden Hospital and Dr Nickolas Papanikolaou from Champalimaud Foundation organised a Workshop with the title:

Practice-oriented Cancer Imaging AI technology applications for clinical use

During the workshop, they focused on explaining questions that the end user should ask the AI developer before choosing and using an AI model.

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!